News

PleoPharma, Inc. Shares Insights on Cannabis Withdrawal Study

PleoPharma, Inc. Shares Insights on Cannabis Withdrawal Study

Introduction to PleoPharma's Recent Findings

PleoPharma, Inc., focused on tackling cannabis-related health issues, recently unveiled significant findings from their Phase 2b clinical trial. This study involved a novel investigational product, PP-01, designed to ease the symptoms of Cannabis Withdrawal Syndrome (CWS) in individuals suffering from Cannabis Use Disorder (CUD). The results were presented during an annual event for experts in the field, drawing attention to the promising potential of this treatment.

Understanding the Clinical Study

The clinical trial was meticulously structured as a multicenter, randomized, double-blind, placebo-controlled study. In this trial, PP-01 was administered in varying doses to evaluate its effectiveness in mitigating withdrawal symptoms among participants with moderate to severe CUD. With a reported average baseline cannabis usage of approximately 4.6 grams per day, the participants of the study were sure to benefit from any significant findings regarding treatment.

Results That Matter

The results of the study were encouraging. PP-01 was found to significantly reduce Cannabis Withdrawal Scores in comparison to the placebo group, indicating a marked improvement in the withdrawal experience of the participants. Along with demonstrating a significant reduction in symptoms, a secondary endpoint indicated that participants who received PP-01 showed a remarkable five-fold increase in abstinence rates just two weeks post-treatment. It was evident that the first week of treatment played a crucial role in predicting ongoing abstinence.

Participant Experiences and Safety Data

Throughout the trial, PP-01 demonstrated a good safety profile, with the majority of adverse events being mild in nature. These included common side effects such as headache, fatigue, and dizziness, which were manageable and did not compromise the trial's integrity. Importantly, no serious adverse events were reported, which is a significant consideration in the evaluation of any new treatment protocol.

Expert Insights on PP-01

Experts were thrilled to present PP-01's potential benefits at the conference, especially with FDA granting it Fast Track designation. Dr. Shelli Graham, Senior Vice-President of Medical/Clinical Research, expressed enthusiasm about PP-01, noting it could potentially be the first FDA-approved treatment for individuals battling withdrawal symptoms associated with CUD—an area currently underserved in medical offerings.

Broader Context of Cannabis Withdrawal

Understanding the landscape of cannabis dependence is crucial. Recent statistics indicated a growing number of Americans struggling with CUD, highlighting a critical need for effective treatments. The U.S. reported that approximately 19.2 million individuals were affected by CUD, with an increasing number seeking treatment annually. Yet, despite this rising demand, there remain no approved medications specifically targeting CWS or CUD.

PleoPharma's Commitment to Innovation

PleoPharma, Inc. is positioned as a leader in clinical development within the neuropsych and addiction sectors. Their commitment to advancing PP-01 as a viable treatment underscores the company's dedication to helping those affected by CWS and CUD. With a world-class management team and significant experience in gaining regulatory approvals, PleoPharma is poised to make a meaningful impact on public health.

Looking Ahead

The journey to finalize PP-01 continues as PleoPharma prepares to progress into Phase 3 trials. This next step is vital as they aim to further validate the efficacy and safety of this treatment option in a larger population. The company is invested in not just developing medications but ensuring they meet the needs of those living with cannabis use disorders.

Frequently Asked Questions

What is PP-01?

PP-01 is an investigational product designed to alleviate symptoms of Cannabis Withdrawal Syndrome in individuals with Cannabis Use Disorder.

What were the main findings of the Phase 2b trial?

The trial demonstrated that PP-01 significantly reduced withdrawal symptoms and increased cannabis abstinence rates compared to placebo.

How was the PP-01 trial structured?

The study was a multicenter, randomized, double-blind, placebo-controlled trial involving participants with moderate to severe Cannabis Use Disorder.

What side effects were reported during the trial?

The most common side effects included headache, fatigue, and dizziness, all of which were considered mild.

Why is the FDA's Fast Track designation important?

This designation allows for expedited development and review of drugs that target serious conditions and fill unmet medical needs, which is crucial for PP-01.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 81

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 107

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 86

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 95

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 98

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 39

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 136

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 29

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 85

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading

Top 5 Most Recently Viewed Articles

Cascade Milling Enhances Operations with New Facility Expansion

Updated Category News Views 988

Expansion Plans at Cascade Milling Cascade Milling is thrilled to announce the expansion of its organic flour milling facility. This extensive enhancement involves adding a new building dedicated to boosting production. With organic products becoming increasingly popular, this expansion will help the company meet the growing demands for quality organic flours, grains, and...

Continue Reading
Dollar Tree's Stock Trends: What Investors Should Know Now

Updated Category News Views 158

Dollar Tree Inc. Stock Shows Promising Growth Dollar Tree Inc. (NASDAQ: DLTR) shares are experiencing upward movement recently, indicating a possible emerging trend. Notably, the stock seems to be gaining momentum. Market Dynamics and Recent Developments After being deemed oversold, Dollar Tree's stock has gained interest, particularly following recent earnings reports...

Continue Reading
Important Update for Workhorse Group Shareholders About Call

Updated Category News Views 141

Engaging Shareholders Ahead of Upcoming Conference Call In a crucial step to engage with shareholders, Workhorse Group Inc. (Nasdaq: WKHS) is gearing up for a conference call designed to address significant updates. This call is an opportunity for shareholders to discuss the company's important financial results and recently announced transactions. Call Details for...

Continue Reading
LeafLink's Strategic Acquisition of Leaf Trade to Boost Growth

Updated Category News Views 222

LeafLink Expands Horizons with Leaf Trade Acquisition LeafLink, a prominent name in the cannabis wholesale industry, has recently made headlines with its acquisition of Leaf Trade. This strategic move is set to create a significant impact on the market by streamlining operations and addressing the growing needs of multi-state operators (MSOs) and enterprise-level cannabis...

Continue Reading
Florida's First Behavioral Health Teaching Hospital Unveiled

Updated Category News Views 189

Welcoming Florida's First Behavioral Health Teaching Hospital The TGH Behavioral Health Hospital represents a significant milestone in mental health treatment. This facility offers specialized and personalized care for various behavioral and mental health conditions. Inauguration Ceremony at TGH Recently, leaders from Tampa General Hospital (TGH), Lifepoint Health, and...

Continue Reading